This inventor holds 1 USPTO granted patent. Top assignees: Ajou University Industry-Academic Cooperation Foundation, University-Industry Cooperation Group of Kyung Hee University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 386 
1 out of 638 Years Active: 2026
Title: Dae-Hyun Hahm: Innovator in Anti-Inflammatory Research
Introduction
Dae-Hyun Hahm is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the development of small molecule inhibitors for treating autoimmune and inflammatory diseases. His innovative work has the potential to change the landscape of therapeutic options available for these conditions.
Latest Patents
Dae-Hyun Hahm holds a patent for a Tumor Necrosis Factor Alpha (TNF-alpha) small molecule inhibitor. This compound is designed to inhibit the formation of a TNF-α homotrimer by specifically binding to the binding cavity of a TNF-α homodimer. The patent outlines a composition containing this compound, along with its uses in preventing or treating autoimmune diseases and inflammatory diseases. The extracellular inactivation of TNF-α through protein-protein interface destruction represents a groundbreaking method for alleviating chronic systemic inflammatory states. The TIM series compounds developed by Hahm exhibit better efficacy and lower toxicity compared to existing TNF inhibitors, along with oral bioavailability, making them promising candidates as leading anti-inflammatory molecules.
Career Highlights
Throughout his career, Dae-Hyun Hahm has been associated with notable institutions such as the Ajou University Industry-Academic Cooperation Foundation and the University-Industry Cooperation Group of Kyung Hee University. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Dae-Hyun Hahm has worked alongside talented individuals such as Mahesh Chandra Patra and Nasir Javaid. Their collaborative efforts have contributed to the success of his research and the development of innovative solutions in the medical field.
Conclusion
Dae-Hyun Hahm is a distinguished inventor whose work in developing TNF-alpha inhibitors showcases his commitment to advancing medical science. His innovative approaches have the potential to significantly impact the treatment of autoimmune and inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile